Functional outcomes in the treatment of adults with ADHD

Journal of Attention Disorders

Volumn 11, Issue 6, 2008, Pages 720-727

  Adler, Lenard A ^a   Spencer, Thomas J ^b   Levine, Louise R ^c   Ramsey, Janet L ^c   Tamura, Roy ^c   Kelsey, Douglas ^c   Ball, Susan G ^c   Allen, Albert J ^c   Biederman, Joseph ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Lilly Research Laboratories

Author keywords

AAQoL; ADHD; Atomoxetine; EWPS; Functional outcomes; Long term

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; PRODUCTIVITY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; EFFICIENCY; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 41849096742     PISSN: 10870547     EISSN: None     Source Type: Journal    
DOI: 10.1177/1087054707308490     Document Type: Article

References (23)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual for mental disorders (4 th ed., text revision). Washington, DC: Author.
2. Barkley, R. (2004). Driving impairments in teens and adults with attention-deficit hyperactivity disorder. Psychiatric Clinics of North America, 27, 233-260.
3. Barkley, R.A. (2002). Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 63, 10-15.
4. Barkley, R.A., Murphy, K.R., DuPaul, G.J., & Bush, T. (2002). Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes, and the role of executive functioning. Journal of the International Neuropsychological Society, 8, 655-672.
5. Biederman, J., Faraone, S.V., Spencer, T.J., Mick, E., Monuteaux, M.C., & Aleardi, M. (2006). Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. Journal of Clinical Psychiatry, 67, 524-540.
6. Biederman, J., Mick, E., & Faraone, S. (2000). Age-dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type. American Journal of Psychiatry, 157, 816-818.
7. Brod, M., Perwien, A., Adler, L., Spencer, T., & Johnston, J. (2005). Conceptualization and assessment of quality of life for adults with attention deficit/hyperactivity disorder. Primary Psychiatry, 12, 58-64.
8. Conners, C.K., Erhardt, D., & Sparrow, E. (1999). Conners' Adult ADHD Rating Scales (CAARS). North Tonawanda, NY: Multi-Health Systems.
9. Endicott, J., & Nee, J. (1997). Endicott Work Productivity Scale (EWPS): A new measure to assess treatment effects. Psychopharmacology Bulletin, 33, 13-16.
10. Epstein, J., Johnson, D., & Conners, K.C. (2001). Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID). North Tonwanda, NY: Multi-Health Systems.
11. Faraone, S.V., Biederman, J., Spencer, T., Wilens, T., Seidman, L.J., Mick, E., et al. (2000). Attention-deficit/ hyperactivity disorder in adults: An overview. Biological Psychiatry, 48, 9-20.
12. First, M.B., Spitzer, R.L., Gibbons, M., & Williams, J.B. (1995). Structured clinical interview for the DSM-IV Axis I disorders. New York: New York State Psychiatric Institute, Biometrics Research Department.
13. Guy, W. (1976). ECDEU assessment manual for psychopharmacology, revised. Bethesda, MD: U.S. Department of Health, Education, and Welfare.
14. Kessler, R.C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., et al. (2005). The World Health Organization adult ADHD self-report scale (ASRS): A short screening scale for use in the general population. Psychological Medicine, 35, 245-256.
15. Kessler, R.C., Adler, L., Barkley, R., Biederman, J., Conners, C.K., Demler, O., et al. (2006). Prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry, 163, 716-723.
16. Kessler, R.C., Adler, L.A., Barkley, R., Biederman, J., Conners, C.K., Faraone, S.V., et al. (2005). Patterns and predictors of attention-deficit/ hyperactivity disorder persistence into adulthood: Results from the National Comorbidity Survey Replication. Biological Psychiatry, 57, 1442-1451.
17. Levine, L.R., Tollefson, G.D., Tamura, R., Rogers, A.K., Detke, H.C., & Allen, A.J. (2004, October). An analysis of baseline functional disability in a cohort of employed adult patients with attention deficit hyperactivity disorder. Poster presented at the American Academy of Child and Adolescent Psychiatry national conference, Washington, DC.
18. McManus, P., Mant, A., Mitchell, P., & Dudley, J. (2004). Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia. Australian and New Zealand Journal of Psychiatry, 38, 450-454.
19. Michelson, D., Adler, L., Spencer, T., Reimherr, F.W., West, S.A., Allen, A.J., et al. (2003). Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biological Psychiatry, 53, 112-120.
20. Secknik, K., Swensen, A., & Lage, M.G. (2005). Comorbidities and costs of adult patients diagnosed with attention deficit hyperactivity disorder. Pharmacoeconomics, 23, 93-102.
21. Sobanski, E. (2006). Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). European Archives of Psychiatry and Clinical Neuroscience, 256 (Suppl. 1). 126-131.
22. Spencer, T.J., Biederman, J., & Mick, E. (2007). Attention-deficit/ hyperactivity disorder: Diagnosis, lifespan, comorbidities, and neurobiology. Ambulatory Pediatrics, 7, 73-81.
23. World Medical Association. (2000). Declaration of Helsinki: Ethical principles for medical research involving human participants (Rev.). Available from http://www.wma.net/e/policy/17-c_e.html